News & Views

Media Coverage

POZ: FDA Approval of PrEP for Adolescents is a Great Start, Writes Council Expert

Council researcher Nanlesta Pilgrim writes about the U.S. Food and Drug Administration (FDA)'s recent decision to expand the approval of Truvada as pre-exposure prophylaxis (PrEP) against HIV for use in at-risk adolescents and the continued need to improve services for adolescents, in the U.S. and around the world. 

Read more

Media Coverage

The Daily Nation: Reliable Data Can Aid Fight Against Female Genital Mutilation

*This op-ed was orinially published in the Feb. 6th print edition of The Daily Nation, the Kenyan newspaper.

There are many things we know – with certainty – about female genital mutilation/cutting (FGM/C). We know that more than 200 million women and girls in the world have undergone FGM/C. We know that it happens in parts of Kenya – and that it is against the law in this country. While the evidence of FGM/C’s physical and mental harms is well-documented, we know there are people who support it as a cultural practice. We also know that many people are against it: people who see an obligation to respect the human rights of girls and women.  

Read more